Finally, emerging high throughput technologies, such as exome sequencing, will be valuable for detecting disease-causing variants of TP53 in salivary gland neoplasms just as in some other types of cancer, such as oral cancer [36], [37], [38]. This evidence concerns the gene TP53 and cancer.